Replies to post #1102 on Revance Therapeutics Inc (RVNC)

[Lishur]

Looks positive..all the best

[DewDiligence]

Latest investor slide set (7/24/19):

https://investors.revance.com/static-files/fa582118-0191-44ae-b904-bb3d91e0fc1c

[DewDiligence]

RVNC 2Q19 CC transcript:

https://finance.yahoo.com/news/edited-transcript-rvnc-earnings-conference-112300104.html

[DewDiligence]

RVNC 3Q19 results—pro-forma cash=$214M*:

https://investors.revance.com/news-releases/news-release-details/revance-completes-enrollment-aspen-1-phase-3-pivotal-trial

The BLA will be submitted during November, according to the PR.

Guidance for 2019 operating cash burn remains unchanged at $148-158M.

*Including $5M payment from Mylan, which has not yet been received.